Human Papillomavirus (HPV)
Most new HPV infections clear on their own within 2 years. However, for some women, the infection doesn’t go away. While there are vaccines available that prevent HPV, these vaccines are not effective against HPV infections already present in women. As a result, there is a need for therapeutic vaccines that target persistent HPV infections of the cervix.
- This study is evaluating three investigational therapeutic vaccines against placebo. Placebo looks like the investigational vaccines, but contains no active vaccine. The investigational vaccines being evaluated in this study have not been approved to treat persistent HPV infections. They are considered under investigation and are only available in studies like this one. The results of this study will provide more information about the safety of the investigational vaccines and their efficacy in persistent HPV16 and HPV18 infections in women.
- Be a woman who is 18 to 60 years of age
- Have been diagnosed with persistent HPV16 or HPV18 infection of the cervix for at least 12 months
- Not have a diagnosis of both HPV16 and HPV18
If Qualified & you Participate you will Receive;
- All study-required visits, tests, and investigational vaccines will be provided at no cost. In addition, reimbursement for study-required travel will be provided up to $125 per completed visit, there will be approximentely 14 visits per participant.